View source for 2bro

[[Image:2bro.gif|left|200px]]

<!--
The line below this paragraph, containing "STRUCTURE_2bro", creates the "Structure Box" on the page.
You may change the PDB parameter (which sets the PDB file loaded into the applet) 
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
or leave the SCENE parameter empty for the default display.
-->
{{STRUCTURE_2bro|  PDB=2bro  |  SCENE=  }} 

'''STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY'''


==Overview==
We report the discovery, synthesis, and crystallographic binding mode of novel furanopyrimidine and pyrrolopyrimidine inhibitors of the Chk1 kinase, an oncology target. These inhibitors are synthetically tractable and inhibit Chk1 by competing for its ATP site. A chronological account allows an objective comparison of modeled compound docking modes to the subsequently obtained crystal structures. The comparison provides insights regarding the interpretation of modeling results, in relationship to the multiple reasonable docking modes which may be obtained in a kinase-ATP site. The crystal structures were used to guide medicinal chemistry efforts. This led to a thorough characterization of a pair of ligand-protein complexes which differ by a single hydrogen bond. An analysis indicates that this hydrogen bond is expected to contribute a fraction of the 10-fold change in binding affinity, adding a valuable observation to the debate about the energetic role of hydrogen bonding in molecular recognition.

==About this Structure==
2BRO is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2BRO OCA]. 

==Reference==
Structure-based design of novel Chk1 inhibitors: insights into hydrogen bonding and protein-ligand affinity., Foloppe N, Fisher LM, Howes R, Kierstan P, Potter A, Robertson AG, Surgenor AE, J Med Chem. 2005 Jun 30;48(13):4332-45. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/15974586 15974586]
[[Category: Homo sapiens]]
[[Category: Non-specific serine/threonine protein kinase]]
[[Category: Single protein]]
[[Category: Fisher, L M.]]
[[Category: Foloppe, N.]]
[[Category: Howes, R.]]
[[Category: Kierstan, P.]]
[[Category: Potter, A.]]
[[Category: Robertson, A G.S.]]
[[Category: Surgenor, A E.]]
[[Category: Atp-binding]]
[[Category: Cell cycle]]
[[Category: Dna damage]]
[[Category: Drug design]]
[[Category: Furanopyrimidine]]
[[Category: Kinase]]
[[Category: Molecular recognition]]
[[Category: Nuclear protein]]
[[Category: Oncology]]
[[Category: Phosphorylation]]
[[Category: Polymorphism]]
[[Category: Pyrrolopyrimidine]]
[[Category: Serine/threonine-protein kinase]]
[[Category: Transferase]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May  3 20:42:15 2008''